ABSTRACT
Human embryonic stem cells (hESCs) represent a great potential source of cells for therapeutic uses, including cell therapy, and for required prior research, basic or translational. Parkinson’s disease, spinal cord injury, heart failure and bone marrow failure are examples of pathological conditions amenable to being corrected by means of stem cell transplantation.1,2
However, the regenerative medicine applications of ESCs are only one aspect of hESC research potential. They are an invaluable research tool to study human development, and can serve as a platform to develop and test new drugs and treatment protocols.3
